Alkermes plc (ALKS)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 23.85 |
| Open | 24.08 |
| Bid | 24.04 x 600 |
| Ask | 24.11 x 200 |
| Day's range | 23.76 - 24.19 |
| 52-week range | 22.01 - 33.71 |
| Volume | |
| Avg. volume | 1,998,685 |
| Market cap | 4.072B |
| Beta (5Y monthly) | 0.55 |
| PE ratio (TTM) | 7.87 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Will Alkermes' (ALKS) Proprietary Drugs Aid Amid Competition?
Alkermes (ALKS) expects its set of proprietary products, Vivitrol, Aristada and Lybalvi, to generate incremental sales and combat stiff competition in 2024.
- Investor's Business Daily
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
The top five biotech stocks today have several commonalities. Among them are strong ratings. Some show promising charts and are Tech Leaders.
- Zacks
Alkermes (ALKS) Earnings Expected to Grow: What to Know Ahead of Q1 Release
Alkermes (ALKS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
© 2024 Yahoo. All rights reserved.